NovoCure Ltd. (NVCR)

14.76 +3.02 (+25.72%) USD  |  NASDAQ  |  Feb 25, 11:41
More

NovoCure Cash from Discontinued Operations Adjustment (Quarterly)

Cash from Discontinued Operations Adjustment (Quarterly) Chart

View Cash from Discontinued Operations Adjustment (Quarterly) for NVCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Discontinued Operations Adjustment (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years

View Cash from Discontinued Operations Adjustment (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks

View Cash from Discontinued Operations Adjustment (Quarterly) Benchmarks
Start Trial
LivaNova Plc --
AtriCure, Inc. --
Abbott Laboratories --
Accuray, Inc. --
Plus Therapeutics, Inc. --